<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:TRIL (Canada) Also Trade In: Canada Germany UK

Trillium Therapeutics Inc $ 0.29 0.01 (1.9%)

Volume:
329,896
Avg Vol (1m):
197,747
Market Cap $:
8.54 Mil
Enterprise Value $:
1.03 Mil
P/E (TTM):
0.00
P/B:
3.10
Warning! GuruFocus has detected 3 Severe warning signs with TRIL. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

6.2/10
Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.71
N/A
Piotroski F-Score 3
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -6.76
DISTRESS
GREY
SAFE
WACC vs ROIC
ROIC 0%
WACC 14.7%

Profitability

2/10
Current Vs Industry Vs History
Operating Margin % -138888.24
Net Margin % -114055.88
ROE % -83.54
ROA % -62.56
ROC (Joel Greenblatt) % -1427.53
3-Year EBITDA Growth Rate -9.8
3-Year EPS without NRI Growth Rate -11.3

Ratios

Current Vs Industry Vs History
PB Ratio 3.1
EV-to-EBIT -0.05
N/A
EV-to-EBITDA -0.05
N/A
EV-to-Revenue 41.14
Current Ratio 3.43
Quick Ratio 3.43
Days Sales Outstanding 7

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -25.2

Valuation & Return

Current Vs Industry Vs History
Price-to-Median-PS-Value 0.85
Earnings Yield (Greenblatt) % -2547.19